| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 4, 2026 | ±1.7% | +0.1% | over-priced |
| November 5, 2025 | ±3.3% | +0.4% | over-priced |
| August 4, 2025 | ±2.5% | +2.4% | over-priced |
| May 2, 2025 | ±2.3% | +0.8% | over-priced |
| November 1, 2024 | ±2.3% | -0.0% | over-priced |
| August 2, 2024 | ±2.3% | +2.5% | under-priced |
| May 3, 2024 | ±2.0% | -1.7% | over-priced |
| November 6, 2023 | ±2.4% | -2.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | — | $412M | $133M |
| Q4 FY2025 | — | $404M | $208M |
| Q3 FY2025 | — | $388M | $113M |
| Q2 FY2025 | — | $381M | $108M |
Regency Centers Corporation (REG) reports in 97 days, with the next report estimated for September 18, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced REG's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 8.3%. QuantLogix's live 5-factor engine currently reads REG as a buy at 59/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →